Literature DB >> 1782548

Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease.

P Cras1, M Kawai, S Siedlak, G Perry.   

Abstract

When neurons die, the filaments of neurofibrillary tangles (NFT) undergo structural and antigenic modifications. The exact mechanism of this modification is unknown, but glial cells could play an important role. Previous studies have shown that astroglial processes infiltrate extracellular NFT. In this study we use double immunolabelling to show that microglia also infiltrate extracellular NFT. Therefore, along with the previously identified astroglia, the microglia could be responsible for the modification of extracellular NFT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782548     DOI: 10.1016/0006-8993(91)90783-r

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  Evidence that neurofibrillary tangles undergo glial modification.

Authors:  K Ikeda; H Akiyama; C Haga; S Haga
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.

Authors:  G Perry; P Cras; S L Siedlak; M Tabaton; M Kawai
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

3.  CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.

Authors:  Jeremy Koppel; Valerie Vingtdeux; Philippe Marambaud; Cristina d'Abramo; Heidy Jimenez; Mark Stauber; Rachel Friedman; Peter Davies
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

4.  Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein.

Authors:  Arianna Bellucci; Andrew J Westwood; Esther Ingram; Fiorella Casamenti; Michel Goedert; Maria Grazia Spillantini
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 5.  Oxygen Sensing and Signaling in Alzheimer's Disease: A Breathtaking Story!

Authors:  Sónia C Correia; Paula I Moreira
Journal:  Cell Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.046

6.  CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.

Authors:  Jeremy Koppel; Valerie Vingtdeux; Philippe Marambaud; Cristina d'Abramo; Heidy Jimenez; Mark Stauber; Rachel Friedman; Peter Davies
Journal:  Mol Med       Date:  2014-03-14       Impact factor: 6.354

7.  Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.

Authors:  Thuy-Vi V Nguyen; Lin Shen; Lilith Vander Griend; Lisa N Quach; Nadia P Belichenko; Nay Saw; Tao Yang; Mehrdad Shamloo; Tony Wyss-Coray; Stephen M Massa; Frank M Longo
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  Therapeutic strategies for tau mediated neurodegeneration.

Authors:  Yasumasa Yoshiyama; Virginia M Y Lee; John Q Trojanowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-20       Impact factor: 10.154

9.  Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia. Investigations with cell cultures and human cortical biopsies.

Authors:  A Dahlström; A McRae; R Polinsky; L Nee; B Sadasivan; E A Ling
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

10.  Chronic Intermittent Hypoxia Enhances Pathological Tau Seeding, Propagation, and Accumulation and Exacerbates Alzheimer-like Memory and Synaptic Plasticity Deficits and Molecular Signatures.

Authors:  Syed Faraz Kazim; Abhijeet Sharma; Sivaprakasam R Saroja; Joon Ho Seo; Chloe S Larson; Aarthi Ramakrishnan; Minghui Wang; Robert D Blitzer; Li Shen; Catherine J Peña; John F Crary; Larissa A Shimoda; Bin Zhang; Eric J Nestler; Ana C Pereira
Journal:  Biol Psychiatry       Date:  2021-03-24       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.